Clara Andradas

1.5k total citations
16 papers, 972 citations indexed

About

Clara Andradas is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Clara Andradas has authored 16 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Clara Andradas's work include Cannabis and Cannabinoid Research (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Clara Andradas is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Clara Andradas collaborates with scholars based in Spain, United Kingdom and Australia. Clara Andradas's co-authors include Cristina Sánchez, Eduardo Pérez-Gómez, Manuel Guzmán, María M. Caffarel, Andrew J. Irving, Sandra Blasco-Benito, Guillermo Velasco, María Salazar‐Roa, Mar Lorente and Julia Kargl and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Journal of Medicinal Chemistry.

In The Last Decade

Clara Andradas

16 papers receiving 951 citations

Peers

Countries citing papers authored by Clara Andradas

Since Specialization

Citations

This map shows the geographic impact of Clara Andradas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Andradas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Andradas more than expected).

Fields of papers citing papers by Clara Andradas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Andradas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Andradas. The network helps show where Clara Andradas may publish in the future.

Co-authorship network of co-authors of Clara Andradas

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Andradas. A scholar is included among the top collaborators of Clara Andradas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Andradas. Clara Andradas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma 2021 ·Genome Medicine ·Laura A. Genovesi, (unknown), (unknown), (unknown), (unknown), Marija Kojic, Caterina Brighi, Emily J. Girard, Clara Andradas, (unknown), Dharmesh D. Bhuva, Raelene Endersby, Nicholas G. Gottardo, Anne Bernard, Christelle Adolphe, James M. Olson, Michael D. Taylor, Melissa J. Davis, Brandon J. Wainwright	11
2	Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma 2021 ·Cancers ·Clara Andradas, (unknown), (unknown), (unknown), Anya C. Jones, (unknown), (unknown), (unknown), Lisa Storer, Timothy Ritzmann, Richard G. Grundy, Nicholas G. Gottardo, Raelene Endersby	18
3	The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology 2021 ·Cancers ·Clara Andradas, (unknown), (unknown), Raelene Endersby	13
4	A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma 2020 ·Cancers ·(unknown), Meegan Howlett, (unknown), Chelsea Mayoh, Marie Wong, Paulette Barahona, (unknown), Christine L. White, (unknown), (unknown), Sharon Lee, (unknown), (unknown), Clara Andradas, (unknown), (unknown), Paul G. Ekert, Mark J. Cowley, Nicholas G. Gottardo, Raelene Endersby	4
5	Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer 2018 ·Biochemical Pharmacology ·Sandra Blasco-Benito, (unknown), (unknown), (unknown), Clara Andradas, Elena García-Taboada, (unknown), Stewart Smith, Manuel Guzmán, Eduardo Pérez-Gómez, (unknown), Cristina Sánchez	129
6	Loss of Cannabinoid CB₁Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility 2016 ·Cerebral Cortex ·Javier Díaz-Alonso, Adán de Salas-Quiroga, (unknown), Daniel García-Rincón, Patrícia P. Garcez, Maddy Parsons, Clara Andradas, Cristina Sánchez, François Guillemot, Manuel Guzmán, Ismael Galve‐Roperh	22
7	Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts 2015 ·SpringerPlus ·Jaime Tomé‐Amat, (unknown), (unknown), Eduardo Pérez-Gómez, Clara Andradas, Cristina Sánchez, L Martínez, Álvaro Martínez‐del‐Pozo, José G. Gavilanes, Javier Lacadena	24
8	Selective, Nontoxic CB₂ Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer 2015 ·Journal of Medicinal Chemistry ·Paula Morales, Sandra Blasco-Benito, Clara Andradas, María Gómez‐Cañas, (unknown), Pilar Goya, Javier Fernández‐Ruíz, Cristina Sánchez, Nadine Jagerovic	31
9	New Inhibitors of Angiogenesis with Antitumor Activity in Vivo 2015 ·Journal of Medicinal Chemistry ·Nagore I. Marín‐Ramos, Dulce Alonso, Silvia Ortega‐Gutiérrez, (unknown), (unknown), Henar Vázquez‐Villa, Clara Andradas, Sandra Blasco-Benito, Eduardo Pérez-Gómez, Ángeles Canales, Jesús Jiménez‐Barbero, (unknown), Jaime Moscoso del Prado, Cristina Sánchez, Mar Martín‐Fontecha, María L. López-Rodrı́guez	17
10	Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling 2014 ·Journal of Biological Chemistry ·Estefanía Moreno, Clara Andradas, Mireia Medrano, María M. Caffarel, Eduardo Pérez-Gómez, Sandra Blasco-Benito, María Gómez‐Cañas, M. Ruth Pazos, Andrew J. Irving, Carme Lluı́s, Enric I. Canela, Javier Fernández‐Ruíz, Manuel Guzmán, Peter J. McCormick, Cristina Sánchez	89
11	The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas 2012 ·Oncogene ·Eduardo Pérez-Gómez, Clara Andradas, (unknown), Miguel Quintanilla, Jesús M. Paramio, Manuel Guzmán, Cristina Sánchez	82
12	Cannabinoids: A new hope for breast cancer therapy? 2012 ·Cancer Treatment Reviews ·María M. Caffarel, Clara Andradas, Eduardo Pérez-Gómez, Manuel Guzmán, Cristina Sánchez	93
13	Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55 2011 ·Molecular Endocrinology ·Christopher M. Henstridge, Nariman Balenga, Julia Kargl, Clara Andradas, Andrew J. Brown, Andrew J. Irving, Cristina Sánchez, Maria Waldhoer	132
14	Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition 2010 ·Molecular Cancer ·María M. Caffarel, Clara Andradas, E. Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno‐Bueno, (unknown), Isabel García Real, José Palacios, Santos Mañes, Manuel Guzmán, Cristina Sánchez	148
15	The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK 2010 ·Oncogene ·Clara Andradas, María M. Caffarel, Eduardo Pérez-Gómez, María Salazar‐Roa, Mar Lorente, Guillermo Velasco, Manuel Guzmán, Cristina Sánchez	157
16	Antitumoural effect of cannabinoids in an animal model of breast cancer 2008 ·European Journal of Cancer Supplements ·(unknown), Clara Andradas, E. Mira, Camilla Cerutti, Santos Mañes, Marta Guzmán, Cristina Sánchez	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact